Novel compounds of the formula I
1
in which
R, R
1
and R
2
are as defined in Patent claim 1,
are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic illnesses.
化合物I1的新颖化合物,其中R、R1和R2如专利权要求1中定义的那样,是
凝血因子Xa的
抑制剂,可用于预防和/或治疗血栓栓塞疾病。